TY - JOUR
T1 - Association of pharmacological prophylaxis with the risk of pediatric emergence delirium after sevoflurane anesthesia
T2 - An updated network meta-analysis
AU - Wang, Hung Yu
AU - Chen, Tien Yu
AU - Li, Dian Jeng
AU - Lin, Pao Yen
AU - Su, Kuan Pin
AU - Chiang, Min Hsien
AU - Carvalho, Andre F.
AU - Stubbs, Brendon
AU - Tu, Yu Kang
AU - Wu, Yi Cheng
AU - Roerecke, Michael
AU - Smith, Lee
AU - Tseng, Ping Tao
AU - Hung, Kuo Chuan
N1 - Funding Information:
The authors of this work were supported by the following grants: Brendon Stubbs is supported by a Clinical Lectureship ( ICA-CL-2017-03-001 ) jointly funded by Health Education England (HEE) and the National Institute for Health Research (NIHR) . Brendon Stubbs is part funded by the NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust . Brendon Stubbs is also supported by the Maudsley Charity , King's College London and the NIHR South London Collaboration for Leadership in Applied Health Research and Care (CLAHRC) funding. This paper presents independent research. The views expressed in this publication are those of the authors and not necessarily those of the acknowledged institutions.
Publisher Copyright:
© 2021 Elsevier Inc.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/12
Y1 - 2021/12
N2 - Study objective: This updated network meta-analysis aims at exploring whether the concurrent use of midazolam or antiemetics may enhance the efficacy of other pharmacological regimens for delirium prophylaxis in pediatric population after general anesthesia (GA). Design: Network meta-analysis (PROSPERO registration: CRD42020179483). Setting: Postoperative recovery area. Patients: Pediatric patients undergoing GA with sevoflurane. Interventions: Pharmacological interventions applied during GA with sevoflurane. Measurements: This network meta-analysis of randomized controlled trials (RCTs) was conducted with a frequentist model. PubMed, Embase, ProQuest, ScienceDirect, Cochrane CENTRAL, ClinicalKey, Web of Science, and ClinicalTrials.gov were searched from their inception dates to April 12, 2020, for RCTs of either placebo-controlled or active-controlled design containing information on the incidence of emergence delirium in pediatric patients undergoing sevoflurane anesthesia. Main results: Seventy studies comprising 6904 participants were included for the analysis of 30 pharmacological interventions. Based on surface under the cumulative ranking curve (SUCRA) analysis, midazolam was ranked the lowest in therapeutic effect (SUCRA: 20%), while antiemetics as a monotherapy had no effect on delirium prophylaxis. However, there was a trend that most combination therapies with midazolam or antiemetics were superior to monotherapies for delirium prophylaxis. Subgroup analyses based on age (i.e., ≤7 years) and a validated scoring system (i.e., the Pediatric Anesthesia Emergence Delirium scale) for delirium also suggested a better efficacy of combination therapies than monotherapies. Overall, combination therapies with midazolam or antiemetics did not have a negative impact on the incidence of postoperative nausea and vomiting, length of stay in the postanesthesia care unit, or time to extubation. The dexmedetomidine-midazolam-antiemetic combination was the most effective strategy for the prevention of emergence delirium. Conclusions: This network meta-analysis suggested that the incorporation of midazolam or antiemetics as adjuncts for combination therapies may have synergistic effects against pediatric postoperative emergence delirium. Future large-scale placebo-controlled RCTs are warranted to validate our findings.
AB - Study objective: This updated network meta-analysis aims at exploring whether the concurrent use of midazolam or antiemetics may enhance the efficacy of other pharmacological regimens for delirium prophylaxis in pediatric population after general anesthesia (GA). Design: Network meta-analysis (PROSPERO registration: CRD42020179483). Setting: Postoperative recovery area. Patients: Pediatric patients undergoing GA with sevoflurane. Interventions: Pharmacological interventions applied during GA with sevoflurane. Measurements: This network meta-analysis of randomized controlled trials (RCTs) was conducted with a frequentist model. PubMed, Embase, ProQuest, ScienceDirect, Cochrane CENTRAL, ClinicalKey, Web of Science, and ClinicalTrials.gov were searched from their inception dates to April 12, 2020, for RCTs of either placebo-controlled or active-controlled design containing information on the incidence of emergence delirium in pediatric patients undergoing sevoflurane anesthesia. Main results: Seventy studies comprising 6904 participants were included for the analysis of 30 pharmacological interventions. Based on surface under the cumulative ranking curve (SUCRA) analysis, midazolam was ranked the lowest in therapeutic effect (SUCRA: 20%), while antiemetics as a monotherapy had no effect on delirium prophylaxis. However, there was a trend that most combination therapies with midazolam or antiemetics were superior to monotherapies for delirium prophylaxis. Subgroup analyses based on age (i.e., ≤7 years) and a validated scoring system (i.e., the Pediatric Anesthesia Emergence Delirium scale) for delirium also suggested a better efficacy of combination therapies than monotherapies. Overall, combination therapies with midazolam or antiemetics did not have a negative impact on the incidence of postoperative nausea and vomiting, length of stay in the postanesthesia care unit, or time to extubation. The dexmedetomidine-midazolam-antiemetic combination was the most effective strategy for the prevention of emergence delirium. Conclusions: This network meta-analysis suggested that the incorporation of midazolam or antiemetics as adjuncts for combination therapies may have synergistic effects against pediatric postoperative emergence delirium. Future large-scale placebo-controlled RCTs are warranted to validate our findings.
KW - Combination therapy
KW - Emergence delirium
KW - Network meta-analysis
KW - Pediatric anesthesia
KW - Sevoflurane
UR - http://www.scopus.com/inward/record.url?scp=85113927492&partnerID=8YFLogxK
U2 - 10.1016/j.jclinane.2021.110488
DO - 10.1016/j.jclinane.2021.110488
M3 - Review article
AN - SCOPUS:85113927492
SN - 0952-8180
VL - 75
JO - Journal of clinical anesthesia
JF - Journal of clinical anesthesia
M1 - 110488
ER -